메뉴 건너뛰기




Volumn 8, Issue 18, 2009, Pages 1763-1770

Interleukin-2 gene transfer potentiates the α-galactosylceramide- stimulated antitumor effect by the induction of TRAIL in NKT and NK cells in mouse models of subcutaneous and metastatic carcinoma

Author keywords

Adenovirus vector; IL 2; NK cells; TRAIL; galcer

Indexed keywords

1 O (ALPHA GALACTOPYRANOSYL) 2 HEXACOSANOYLAMINO 1,3,4 OCTADECANETRIOL; ADENOVIRUS VECTOR; ALPHA GALACTOSYLCERAMIDE; GAMMA INTERFERON; INTERLEUKIN 2; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

EID: 73249141580     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.8.18.9321     Document Type: Article
Times cited : (7)

References (43)
  • 3
    • 0030696696 scopus 로고    scopus 로고
    • CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides
    • Kawano T, Cui J, Koezuka Y, Toura I, Kaneko Y, Motoki K, et al. CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides. Science 1997; 278:1626-9.
    • (1997) Science , vol.278 , pp. 1626-1629
    • Kawano, T.1    Cui, J.2    Koezuka, Y.3    Toura, I.4    Kaneko, Y.5    Motoki, K.6
  • 4
    • 0032547823 scopus 로고    scopus 로고
    • CD1d-restricted recognition of synthetic glycolipid antigens by human natural killer T-cells
    • Spada FM, Koezuka Y, Porcelli SA. CD1d-restricted recognition of synthetic glycolipid antigens by human natural killer T-cells. J Exp Med 1998; 188:1529-34.
    • (1998) J Exp Med , vol.188 , pp. 1529-1534
    • Spada, F.M.1    Koezuka, Y.2    Porcelli, S.A.3
  • 5
    • 13144249230 scopus 로고    scopus 로고
    • Natural killer-like non-specific tumor cell lysis mediated by specific ligand-activated Valpha14 NKT cells
    • Kawano T, Cui J, Koezuka Y, Toura I, Kaneko Y, Sato H, et al. Natural killer-like non-specific tumor cell lysis mediated by specific ligand-activated Valpha14 NKT cells. Proc Natl Acad Sci USA 1998; 95:5690-3.
    • (1998) Proc Natl Acad Sci USA , vol.95 , pp. 5690-5693
    • Kawano, T.1    Cui, J.2    Koezuka, Y.3    Toura, I.4    Kaneko, Y.5    Sato, H.6
  • 6
    • 0032242177 scopus 로고    scopus 로고
    • Antitumor activity of alpha-galactosylceramide, KRN7000, in mice with EL-4 hepatic metastasis and its cytokine production
    • Nakagawa R, Motoki K, Nakamura H, Ueno H, Iijima R, Yamauchi A, et al. Antitumor activity of alpha-galactosylceramide, KRN7000, in mice with EL-4 hepatic metastasis and its cytokine production. Oncol Res 1998; 10:561-8.
    • (1998) Oncol Res , vol.10 , pp. 561-568
    • Nakagawa, R.1    Motoki, K.2    Nakamura, H.3    Ueno, H.4    Iijima, R.5    Yamauchi, A.6
  • 7
    • 0033650499 scopus 로고    scopus 로고
    • Antitumor activity of alpha-galactosylceramide, KRN7000, in mice with the melanoma B16 hepatic metastasis and immunohistological study of tumor infiltrating cells
    • Nakagawa R, Serizawa I, Motoki K, Sato M, Ueno H, Iijima R, et al. Antitumor activity of alpha-galactosylceramide, KRN7000, in mice with the melanoma B16 hepatic metastasis and immunohistological study of tumor infiltrating cells. Oncol Res 2000; 12:51-8.
    • (2000) Oncol Res , vol.12 , pp. 51-58
    • Nakagawa, R.1    Serizawa, I.2    Motoki, K.3    Sato, M.4    Ueno, H.5    Iijima, R.6
  • 8
    • 0036896332 scopus 로고    scopus 로고
    • A phase I study of the natural killer T-cell ligand alpha-galactosylceramide (KRN7000) in patients with solid tumors
    • Giaccone G, Punt CJ, Ando Y, Ruijter R, Nishi N, Peters M, et al. A phase I study of the natural killer T-cell ligand alpha-galactosylceramide (KRN7000) in patients with solid tumors. Clin Cancer Res 2002; 8:3702-9.
    • (2002) Clin Cancer Res , vol.8 , pp. 3702-3709
    • Giaccone, G.1    Punt, C.J.2    Ando, Y.3    Ruijter, R.4    Nishi, N.5    Peters, M.6
  • 9
    • 20144388064 scopus 로고    scopus 로고
    • A phase I study of alpha-galactosylceramide (KRN7000)-pulsed dendritic cells in patients with advanced and recurrent non-small cell lung cancer
    • Ishikawa A, Motohashi S, Ishikawa E, Fuchida H, Higashino K, Otsuji M, et al. A phase I study of alpha-galactosylceramide (KRN7000)-pulsed dendritic cells in patients with advanced and recurrent non-small cell lung cancer. Clin Cancer Res 2005; 11:1910-7.
    • (2005) Clin Cancer Res , vol.11 , pp. 1910-1917
    • Ishikawa, A.1    Motohashi, S.2    Ishikawa, E.3    Fuchida, H.4    Higashino, K.5    Otsuji, M.6
  • 10
    • 33750709275 scopus 로고    scopus 로고
    • A phase I study of in vitro expanded natural killer T-cells in patients with advanced and recurrent non-small cell lung cancer
    • Motohashi S, Ishikawa A, Ishikawa E, Otsuji M, Iizasa T, Hanaoka H, et al. A phase I study of in vitro expanded natural killer T-cells in patients with advanced and recurrent non-small cell lung cancer. Clin Cancer Res 2006; 12:6079-86.
    • (2006) Clin Cancer Res , vol.12 , pp. 6079-6086
    • Motohashi, S.1    Ishikawa, A.2    Ishikawa, E.3    Otsuji, M.4    Iizasa, T.5    Hanaoka, H.6
  • 11
    • 0028478117 scopus 로고
    • Activation of T lymphocytes for the adoptive immunotherapy of cancer
    • Sussman JJ, Shu S, Sondak VK, Chang AE. Activation of T lymphocytes for the adoptive immunotherapy of cancer. Ann Surg Oncol 1994; 1:296-306.
    • (1994) Ann Surg Oncol , vol.1 , pp. 296-306
    • Sussman, J.J.1    Shu, S.2    Sondak, V.K.3    Chang, A.E.4
  • 13
    • 24644458827 scopus 로고    scopus 로고
    • Human natural killer cells: A comprehensive review
    • Sinkovics JG, Horvath JC. Human natural killer cells: a comprehensive review. Int J Oncol 2005; 27:5-47.
    • (2005) Int J Oncol , vol.27 , pp. 5-47
    • Sinkovics, J.G.1    Horvath, J.C.2
  • 15
    • 84944285022 scopus 로고
    • High-dose recombinant interleukin 2 in the treatment of patients with disseminated cancer. Responses, treatment-related morbidity and histologic findings
    • Lotze MT, Chang AE, Seipp CA, Simpson C, Vetto JT, Rosenberg SA. High-dose recombinant interleukin 2 in the treatment of patients with disseminated cancer. Responses, treatment-related morbidity and histologic findings. JAMA 1986; 256:3117-24.
    • (1986) JAMA , vol.256 , pp. 3117-3124
    • Lotze, M.T.1    Chang, A.E.2    Seipp, C.A.3    Simpson, C.4    Vetto, J.T.5    Rosenberg, S.A.6
  • 16
    • 0023023119 scopus 로고
    • Intraperitoneal administration of interleukin-2 in patients with cancer
    • Lotze MT, Custer MC, Rosenberg SA. Intraperitoneal administration of interleukin-2 in patients with cancer. Arch Surg 1986; 121:1373-9.
    • (1986) Arch Surg , vol.121 , pp. 1373-1379
    • Lotze, M.T.1    Custer, M.C.2    Rosenberg, S.A.3
  • 17
    • 0025345935 scopus 로고
    • High-dose recombinant interleukin-2 alone: A regimen with limited activity in the treatment of advanced renal cell carcinoma
    • Abrams JS, Rayner AA, Wiernik PH, Parkinson DR, Eisenberger M, Aronson FR, et al. High-dose recombinant interleukin-2 alone: a regimen with limited activity in the treatment of advanced renal cell carcinoma. J Natl Cancer Inst 1990; 82:1202-6.
    • (1990) J Natl Cancer Inst , vol.82 , pp. 1202-1206
    • Abrams, J.S.1    Rayner, A.A.2    Wiernik, P.H.3    Parkinson, D.R.4    Eisenberger, M.5    Aronson, F.R.6
  • 19
    • 0025000864 scopus 로고
    • Interleukin 2 gene transfer into tumor cells abrogates tumorigenicity and induces protective immunity
    • Gansbacher B, Zier K, Daniels B, Cronin K, Bannerji R, Gilboa E. Interleukin 2 gene transfer into tumor cells abrogates tumorigenicity and induces protective immunity. J Exp Med 1990; 172:1217-24.
    • (1990) J Exp Med , vol.172 , pp. 1217-1224
    • Gansbacher, B.1    Zier, K.2    Daniels, B.3    Cronin, K.4    Bannerji, R.5    Gilboa, E.6
  • 20
    • 0026472495 scopus 로고
    • Retroviral gene transfer induced constitutive expression of interleukin-2 or interferon-gamma in irradiated human melanoma cells
    • Gansbacher B, Zier K, Cronin K, Hantzopoulos PA, Bouchard B, Houghton A, et al. Retroviral gene transfer induced constitutive expression of interleukin-2 or interferon-gamma in irradiated human melanoma cells. Blood 1992; 80:2817-25.
    • (1992) Blood , vol.80 , pp. 2817-2825
    • Gansbacher, B.1    Zier, K.2    Cronin, K.3    Hantzopoulos, P.A.4    Bouchard, B.5    Houghton, A.6
  • 21
    • 0027968048 scopus 로고
    • Adoptive immunotherapy with murine tumor-specific T lymphocytes engineered to secrete interleukin 2
    • Nakamura Y, Wakimoto H, Abe J, Kanegae Y, Saito I, Aoyagi M, et al. Adoptive immunotherapy with murine tumor-specific T lymphocytes engineered to secrete interleukin 2. Cancer Res 1994; 54:5757-60.
    • (1994) Cancer Res , vol.54 , pp. 5757-5760
    • Nakamura, Y.1    Wakimoto, H.2    Abe, J.3    Kanegae, Y.4    Saito, I.5    Aoyagi, M.6
  • 22
    • 4243125420 scopus 로고    scopus 로고
    • Antitumor effect of genetically engineered mesenchymal stem cells in a rat glioma model
    • Nakamura K, Ito Y, Kawano Y, Kurozumi K, Kobune M, Tsuda H, et al. Antitumor effect of genetically engineered mesenchymal stem cells in a rat glioma model. Gene Ther 2004; 11:1155-64.
    • (2004) Gene Ther , vol.11 , pp. 1155-1164
    • Nakamura, K.1    Ito, Y.2    Kawano, Y.3    Kurozumi, K.4    Kobune, M.5    Tsuda, H.6
  • 23
    • 34848861126 scopus 로고    scopus 로고
    • Intratumoral delivery of vector mediated IL-2 in combination with vaccine results in enhanced T-cell avidity and anti-tumor activity
    • Kudo-Saito C, Garnett CT, Wansley EK, Schlom J, Hodge JW. Intratumoral delivery of vector mediated IL-2 in combination with vaccine results in enhanced T-cell avidity and anti-tumor activity. Cancer Immunol Immunother 2007; 56:1897-910.
    • (2007) Cancer Immunol Immunother , vol.56 , pp. 1897-1910
    • Kudo-Saito, C.1    Garnett, C.T.2    Wansley, E.K.3    Schlom, J.4    Hodge, J.W.5
  • 24
    • 0037279047 scopus 로고    scopus 로고
    • Enhanced antitumor effect of RGD fiber-modified adenovirus for gene therapy of oral cancer
    • Dehari H, Ito Y, Nakamura T, Kobune M, Sasaki K, Yonekura N, et al. Enhanced antitumor effect of RGD fiber-modified adenovirus for gene therapy of oral cancer. Cancer Gene Ther 2003; 10:75-85.
    • (2003) Cancer Gene Ther , vol.10 , pp. 75-85
    • Dehari, H.1    Ito, Y.2    Nakamura, T.3    Kobune, M.4    Sasaki, K.5    Yonekura, N.6
  • 25
    • 0036327585 scopus 로고    scopus 로고
    • Dose of adenoviral vectors expressing interleukin-2 plays an important role in combined gene therapy with cytosine deaminase/5-fluorocytosine: Preclinical consideration
    • Nakamori M, Iwahashi M, Ueda K, Tsunoda T, Terasawa H, Hamada H, et al. Dose of adenoviral vectors expressing interleukin-2 plays an important role in combined gene therapy with cytosine deaminase/5-fluorocytosine: preclinical consideration. Jpn J Cancer Res 2002; 93:706-15.
    • (2002) Jpn J Cancer Res , vol.93 , pp. 706-715
    • Nakamori, M.1    Iwahashi, M.2    Ueda, K.3    Tsunoda, T.4    Terasawa, H.5    Hamada, H.6
  • 26
    • 0028037530 scopus 로고
    • A simple and efficient method for purification of infectious recombinant adenovirus
    • Kanegae Y, Makimura M, Saito I. A simple and efficient method for purification of infectious recombinant adenovirus. Jpn J Med Sci Biol 1994; 47:157-66.
    • (1994) Jpn J Med Sci Biol , vol.47 , pp. 157-166
    • Kanegae, Y.1    Makimura, M.2    Saito, I.3
  • 27
    • 0035138146 scopus 로고    scopus 로고
    • Anti-metastatic gene therapy utilizing subcutaneous inoculation of EC-SOD gene transduced autologous fibroblast suppressed lung metastasis of Meth-A cells and 3LL cells in mice
    • Tanaka M, Kogawa K, Nakamura K, Nishihori Y, Kuribayashi K, Hagiwara S, et al. Anti-metastatic gene therapy utilizing subcutaneous inoculation of EC-SOD gene transduced autologous fibroblast suppressed lung metastasis of Meth-A cells and 3LL cells in mice. Gene Ther 2001; 8:149-56.
    • (2001) Gene Ther , vol.8 , pp. 149-156
    • Tanaka, M.1    Kogawa, K.2    Nakamura, K.3    Nishihori, Y.4    Kuribayashi, K.5    Hagiwara, S.6
  • 29
    • 0032698211 scopus 로고    scopus 로고
    • Antitumor cytotoxicity mediated by ligand-activated human V alpha24 NKT cells
    • Kawano T, Nakayama T, Kamada N, Kaneko Y, Harada M, Ogura N, et al. Antitumor cytotoxicity mediated by ligand-activated human V alpha24 NKT cells. Cancer Res 1999; 59:5102-5.
    • (1999) Cancer Res , vol.59 , pp. 5102-5105
    • Kawano, T.1    Nakayama, T.2    Kamada, N.3    Kaneko, Y.4    Harada, M.5    Ogura, N.6
  • 30
    • 0033198183 scopus 로고    scopus 로고
    • Cutting edge: Activation of NK T-cells by CD1d and alpha-galactosylceramide directs conventional T-cells to the acquisition of a Th2 phenotype
    • Singh N, Hong S, Scherer DC, Serizawa I, Burdin N, Kronenberg M, et al. Cutting edge: activation of NK T-cells by CD1d and alpha-galactosylceramide directs conventional T-cells to the acquisition of a Th2 phenotype. J Immunol 1999; 163:2373-7.
    • (1999) J Immunol , vol.163 , pp. 2373-2377
    • Singh, N.1    Hong, S.2    Scherer, D.C.3    Serizawa, I.4    Burdin, N.5    Kronenberg, M.6
  • 31
    • 3042760542 scopus 로고    scopus 로고
    • Regulation of immune responses by CD1d-restricted natural killer T-cells
    • Van Kaer L. Regulation of immune responses by CD1d-restricted natural killer T-cells. Immunol Res 2004; 30:139-53.
    • (2004) Immunol Res , vol.30 , pp. 139-153
    • Van Kaer, L.1
  • 33
    • 0035424975 scopus 로고    scopus 로고
    • CD1-specific T-cells in microbial immunity
    • Gumperz JE, Brenner MB. CD1-specific T-cells in microbial immunity. Curr Opin Immunol 2001; 13:471-8.
    • (2001) Curr Opin Immunol , vol.13 , pp. 471-478
    • Gumperz, J.E.1    Brenner, M.B.2
  • 35
    • 0032521202 scopus 로고    scopus 로고
    • Treatment of hepatic metastasis of the colon26 adenocarcinoma with an alpha-galactosylceramide, KRN7000
    • Nakagawa R, Motoki K, Ueno H, Iijima R, Nakamura H, Kobayashi E, et al. Treatment of hepatic metastasis of the colon26 adenocarcinoma with an alpha-galactosylceramide, KRN7000. Cancer Res 1998; 58:1202-7.
    • (1998) Cancer Res , vol.58 , pp. 1202-1207
    • Nakagawa, R.1    Motoki, K.2    Ueno, H.3    Iijima, R.4    Nakamura, H.5    Kobayashi, E.6
  • 36
    • 0035911242 scopus 로고    scopus 로고
    • Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) contributes to interferon gamma-dependent natural killer cell protection from tumor metastasis
    • Smyth MJ, Cretney E, Takeda K, Wiltrout RH, Sedger LM, Kayagaki N, et al. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) contributes to interferon gamma-dependent natural killer cell protection from tumor metastasis. J Exp Med 2001; 193:661-70.
    • (2001) J Exp Med , vol.193 , pp. 661-670
    • Smyth, M.J.1    Cretney, E.2    Takeda, K.3    Wiltrout, R.H.4    Sedger, L.M.5    Kayagaki, N.6
  • 37
    • 0033025582 scopus 로고    scopus 로고
    • A novel recognition motif of human NKT antigen receptor for a glycolipid ligand
    • Kawano T, Tanaka Y, Shimizu E, Kaneko Y, Kamata N, Sato H, et al. A novel recognition motif of human NKT antigen receptor for a glycolipid ligand. Int Immunol 1999; 11:881-7.
    • (1999) Int Immunol , vol.11 , pp. 881-887
    • Kawano, T.1    Tanaka, Y.2    Shimizu, E.3    Kaneko, Y.4    Kamata, N.5    Sato, H.6
  • 38
    • 0033567099 scopus 로고    scopus 로고
    • Expression and function of TNF-related apoptosis-inducing ligand on murine activated NK cells
    • Kayagaki N, Yamaguchi N, Nakayama M, Takeda K, Akiba H, Tsutsui H, et al. Expression and function of TNF-related apoptosis-inducing ligand on murine activated NK cells. J Immunol 1999; 163:1906-13.
    • (1999) J Immunol , vol.163 , pp. 1906-1913
    • Kayagaki, N.1    Yamaguchi, N.2    Nakayama, M.3    Takeda, K.4    Akiba, H.5    Tsutsui, H.6
  • 39
    • 0037148518 scopus 로고    scopus 로고
    • Critical role for tumor necrosis factor-related apoptosis-inducing ligand in immune surveillance against tumor development
    • Takeda K, Smyth MJ, Cretney E, Hayakawa Y, Kayagaki N, Yagita H, et al. Critical role for tumor necrosis factor-related apoptosis-inducing ligand in immune surveillance against tumor development. J Exp Med 2002; 195:161-9.
    • (2002) J Exp Med , vol.195 , pp. 161-169
    • Takeda, K.1    Smyth, M.J.2    Cretney, E.3    Hayakawa, Y.4    Kayagaki, N.5    Yagita, H.6
  • 40
    • 4944243249 scopus 로고    scopus 로고
    • + T-cells express both TNF-related apoptosis-inducing ligand (TRAIL) and TRAIL receptors but are resistant to TRAIL-mediated cytotoxicity
    • + T-cells express both TNF-related apoptosis-inducing ligand (TRAIL) and TRAIL receptors but are resistant to TRAIL-mediated cytotoxicity. Blood 2004; 104:2418-24.
    • (2004) Blood , vol.104 , pp. 2418-2424
    • Mirandola, P.1    Ponti, C.2    Gobbi, G.3    Sponzilli, I.4    Vaccarezza, M.5    Cocco, L.6
  • 41
    • 0036467427 scopus 로고    scopus 로고
    • Increased susceptibility to tumor initiation and metastasis in TNF-related apoptosis-inducing ligand-deficient mice
    • Cretney E, Takeda K, Yagita H, Glaccum M, Peschon JJ, Smyth MJ. Increased susceptibility to tumor initiation and metastasis in TNF-related apoptosis-inducing ligand-deficient mice. J Immunol 2002; 168:1356-61.
    • (2002) J Immunol , vol.168 , pp. 1356-1361
    • Cretney, E.1    Takeda, K.2    Yagita, H.3    Glaccum, M.4    Peschon, J.J.5    Smyth, M.J.6
  • 42
    • 0942276861 scopus 로고    scopus 로고
    • + NKT cells in human subjects results in highly coordinated secondary activation of acquired and innate immunity
    • + NKT cells in human subjects results in highly coordinated secondary activation of acquired and innate immunity. Blood 2004; 103:383-9.
    • (2004) Blood , vol.103 , pp. 383-389
    • Nieda, M.1    Okai, M.2    Tazbirkova, A.3    Lin, H.4    Yamaura, A.5    Ide, K.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.